We provide the first evidence that feimin expression is elevated in microglia in an HFD model and negatively regulates LD accumulation and inflammation by suppressing the AKT–mTOR pathway, correspondingly alleviating cognitive impairment in the in vivo HFD model. Here, AKT1 is linked to Cognitive impairment.